KR100714408B1 - Method for manufacturing of red ginseng bacillus - Google Patents
Method for manufacturing of red ginseng bacillus Download PDFInfo
- Publication number
- KR100714408B1 KR100714408B1 KR1020040040252A KR20040040252A KR100714408B1 KR 100714408 B1 KR100714408 B1 KR 100714408B1 KR 1020040040252 A KR1020040040252 A KR 1020040040252A KR 20040040252 A KR20040040252 A KR 20040040252A KR 100714408 B1 KR100714408 B1 KR 100714408B1
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- fermentation
- cheonggukjang
- bacillus subtilis
- powder
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 72
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 5
- 238000000034 method Methods 0.000 title abstract description 3
- 241000193830 Bacillus <bacterium> Species 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 30
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 22
- 244000068988 Glycine max Species 0.000 claims abstract description 21
- 238000000855 fermentation Methods 0.000 claims abstract description 21
- 230000004151 fermentation Effects 0.000 claims abstract description 21
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 5
- 238000000227 grinding Methods 0.000 claims abstract 3
- 241000206607 Porphyra umbilicalis Species 0.000 claims abstract 2
- 238000001816 cooling Methods 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 abstract description 8
- 235000013555 soy sauce Nutrition 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 240000004160 Capsicum annuum Species 0.000 abstract description 4
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 abstract description 4
- 235000007862 Capsicum baccatum Nutrition 0.000 abstract description 4
- 239000001728 capsicum frutescens Substances 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 208000004232 Enteritis Diseases 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 2
- 239000002778 food additive Substances 0.000 abstract description 2
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 230000005778 DNA damage Effects 0.000 description 17
- 231100000277 DNA damage Toxicity 0.000 description 17
- 239000000284 extract Substances 0.000 description 15
- 238000010790 dilution Methods 0.000 description 13
- 239000012895 dilution Substances 0.000 description 13
- 244000005700 microbiome Species 0.000 description 7
- 239000011812 mixed powder Substances 0.000 description 7
- 230000003091 anti-genotoxic effect Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000003927 comet assay Methods 0.000 description 4
- 231100000170 comet assay Toxicity 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000190633 Cordyceps Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 244000294411 Mirabilis expansa Species 0.000 description 3
- 235000015429 Mirabilis expansa Nutrition 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 231100000357 carcinogen Toxicity 0.000 description 3
- 239000003183 carcinogenic agent Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013536 miso Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010004016 Bacterial diarrhoea Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 231100000024 genotoxic Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
Abstract
본 발명은 홍삼된장, 홍삼간장, 홍삼고추장, 홍삼청국장에 첨가할 홍삼바실루스 서브틸리스균의 제조방법에 관한 것으로서, 구체적인 것은 콩을 삶아서 한 김을 식힌다음 소쿠리에 담아서 서로 어긋나게 포개어 42~45℃의 온도를 유지하는 발효실에 넣고 48시간 발효시키는 1차 발효단계와The present invention relates to a method for producing red ginseng Bacillus subtilis bacteria to be added to red ginseng soybean paste, red ginseng soy sauce, red ginseng pepper paste, red ginseng cheongukjang, specifically, boiled soybeans and cooled by laver soaking in a colander to overlap each other at 42-45 ° C. The first fermentation step is put into a fermentation chamber maintaining the temperature for 48 hours
발효실에서 인출한 발효물을 10℃로 식힌다음 스크류 파쇄기에 투입하여 으깨면서 준비한 홍삼분말을 혼합하는 혼합단계와After cooling the fermented product extracted from the fermentation room to 10 ℃ and put into a screw crusher and mixing the red ginseng powder prepared while crushing
홍삼분말이 혼합된 파쇄물을 소쿠리에 담아 35~38℃를 유지하는 발효실에서 25시간 발효시키는 2차 발효단계와 2차 발효된 발효물을 55~60℃에서 건조시키는 건조단계와 건조된 혼합물을 분쇄기로 분쇄하여 분말하는 단계를 순차적으로 실시하여 얻어지는 홍삼이 혼합된 바실루 서브틸리스균의 제조방법인데 이렇게 함으로써 콩에서 1차 발효된 바실루 서브틸리스균이 홍삼에서 한번더 발효되어 기존의 청국장보다 식중독이나 장염 세균성, 설사등을 방지하는 효과가 있고 당뇨, 혈압에도 좋은 효과를 내게 되어 각종 장류나 기능성 식품첨가제로 이용될 수 있는 홍삼 바실루 서브틸리스균을 얻어 홍삼된장, 홍삼간장, 홍삼고추장, 홍삼청국장을 제조할 수 있게 한 것이다.Secondary fermentation step of fermenting red ginseng powder mixed in colander for 25 hours in fermentation chamber maintaining 35 ~ 38 ℃, drying step of fermenting secondary fermented product at 55 ~ 60 ℃ and grinding mixture A method of producing Bacillus subtilis bacteria, which is a mixture of red ginseng, obtained by sequentially pulverizing and powdering with red ginseng. It is effective in preventing bacteria, diarrhea, enteritis, diabetes and blood pressure, and can be used as various foods and functional food additives to obtain red ginseng bacillus subtilis bacillus, red ginseng soy sauce, red ginseng red pepper paste, red ginseng Cheonggukjang is to be made.
홍삼, 고추장, 청국장, 바실루 서브틸리스균Red ginseng, Gochujang, Cheonggukjang, Bacillus subtilis
Description
본 발명은 홍삼된장, 홍삼간장, 홍삼고추장, 홍삼청국장에 첨가할 홍삼이 혼합된 바실루 서브틸리스균의 제조방법에 관한 것이다.The present invention relates to a red ginseng soybean paste, red ginseng soy sauce, red ginseng red pepper paste, red ginseng to be added to the red ginseng soy sauce mixed bacillus subtilis bacteria.
홍삼은 인삼을 증숙 또는 팽숙하거나 기타의 방법으로 인삼의 녹말을 호화한것을 말하는 것이며 Red ginseng refers to steaming or swelling ginseng or gelatinizing starch of ginseng by other means.
홍삼은 중추신경에 대해서 진정작용과 흥분작용이 있으며, 순환계에 작용하여 고혈압이나 동맥경화를 예방하는 효과가 있는 것으로 밝혀져 있다.Red ginseng has a sedative and arousing effect on the central nervous system, and has been shown to be effective in preventing hypertension and arteriosclerosis by acting on the circulatory system.
그러면서도 조혈작용(造血作用)과 혈당치(血糖値)를 저하시켜주고, 간을 보호하며, 내분비계에 작용하여 성행동이나 생식효과에 간접적으로 유효하게 작용하며, 항염(抗炎) 및 항종양작용(抗腫瘍作用)이 있고, 방사선에 대한 방어효과, 피부를 부드럽게 하는 작용도 있는 것으로 알려져 있다.It also reduces hematopoietic and blood sugar levels, protects the liver, and acts indirectly on sexual and reproductive effects by acting on the endocrine system. Anti-inflammatory and anti-tumor effects (抗 腫 瘍 作用) has a protective effect against radiation, it is also known to soften the skin.
또, 홍삼의 효과 중 중요한 것은 어댑토겐(adaptogen)효과로서 주위 환경으로부터 오는 각종 유해작용 스트레스 등에 대해 방어능력을 증가시켜 생체가 보다 쉽게 적응하도록 하는 능력이 있음이 과학적으로 입증되어 있고,In addition, the most important of the effects of red ginseng is the adaptogen effect, which has been scientifically proven to increase the defense ability against various harmful effects stresses from the surrounding environment and to make the body adapt more easily.
콩에는 단백질이 41%나 들어 있다. 단백질 양은 농작물 중에서 최고이며 구성아미노산의 종류도 육류에 비해 뒤떨어지지 않는다. Soy contains 41% protein. The amount of protein is the highest among crops, and the composition of amino acids is inferior to meat.
리신과 트립토판의 필수아니노산이 콩속에 많이 들어있어 영양적으로 고기를 먹는 것보다 좋다.Lysine and tryptophan are essential in the soybeans because they contain a lot of essential nutrition than meat.
콩은 혈중 콜레스테롤 양을 낮춰줘서 동맥경화, 심근경색, 뇌졸중 및 고혈압 등을 예방하거나 치료식으로 사용될수 있으며Soybeans can be used to prevent or treat arteriosclerosis, myocardial infarction, stroke and high blood pressure by lowering the amount of cholesterol in the blood.
콩속의 식이섬유소, 다가불포화지방산(주로 니놀레산;51%), 사포닌, 트립신저해제 등은 콜레스테롤치를 낮추거나 암예방효과가 있어 중요한 것으로 알려져 있고Dietary fiber, polyunsaturated fatty acids (mainly nioleic acid; 51%), saponins, and trypsin inhibitors in soybeans are known to be important because they lower cholesterol levels or prevent cancer.
콩기름에 들어있는 레시틴은 콜레스테롤치를 낮추거나 노인성치매 예방에도 좋은 것으로 알려져 있다.Lecithin in soybean oil is known to lower cholesterol and prevent senile dementia.
한편 공기름에는 비타민 E가 20mg/100g 가량 있는데 미용과 노화방지에 효과가 있다.On the other hand, air has about 20mg / 100g of vitamin E, which is effective for beauty and anti-aging.
우리나라는 콩을 이용, 일찍이 발효식품을 개발하여 장문화를 발전시켰다. 메주는 10월에 수확한 햇콩을 원료로 만드는데 콩을 삶아 찧어 만든다. 메주의 모양은 다양하지만 일반적으로 8*12*120cm3로 성형하며 Korea developed soybean culture by developing fermented foods using soybeans. Meju is made from raw soybeans harvested in October, and the beans are boiled. Although the shape of the meju varies, it is generally molded into 8 * 12 * 120cm 3
전통적으로는 성형된 메주를 말리고 새끼줄로 메주를 묶어 처마에 달아놓고 자연발효를 한다.Traditionally, dried shaped meju is dried, tied with melon and tied to the eaves to ferment naturally.
메주발효는 된장맛을 내는데 중요한 과정이다.Meju fermentation is an important process for making miso.
콩에는 바실루 서브틸리스균(고초균)이 포자로 붙어 있어 콩을 삶은후 메주를 성형한 다음에도 이 균이 주요 자연발효균으로 활동하며, 또 한 새끼줄에도 자연히 바실루 서브틸리스균들이 많아 메주의 주발효균이며 건조메주의 주위에는 곰팡이 등 다른 균들이 또한 발효에 참여하여 전통메주를 제조한다. Bacillus subtilis bacteria (chocobacteria) are attached to the spores, and after the beans have been boiled, they are also the main spontaneous fermentation bacteria. It is a fermented bacterium and other bacteria, such as mold, are also involved in fermentation to produce traditional meju.
흥미있는 것은 본 실험실 연구에서 콩보다 발효된 메주가 암예방, 항암효과가 크게 증대되었는데 더 확인 연구가 필요하지만 전통식 각메주보다 표면적이 넓은 콩알메주가 효과가 높았다. Interestingly, the fermented meju in the laboratory study significantly improved cancer prevention and anticancer effects. Soybean meju, which has a larger surface area than traditional sake meju, was more effective.
지금까지 미생물을 연구하여온 자료들을 살펴보면, 미생물의 균주가 어느 종류인가 또는 새로 발견된 종류인가 하는 내용위주로 특허를 출원하는 등 관심이 모아지고 있는 것이 현실입니다.Looking at the data that have been studied microorganisms until now, the reality is that the interest is attracting, such as applying for a patent focusing on the type of microorganism strain or newly discovered type.
그러나 페니실린 그 이상의 물질을 개발하려면, 미생물이 강하게 자극을 받았을 때 또는 미생물을 배양할 때 그 숙주가 무엇인가 하는데 더 관심을 가져야 한다고 봅니다.But if we want to develop more than penicillin, we need to be more concerned about what the host is when it is strongly stimulated or when it is cultured.
대기 중에 날아다니던 미생물이 벌레에서 붙어서 겨울에는 벌레속에서 영향을 섭취하고 여름에는 버섯처럼 자라는 현상을 동충하초라고 하는데, 동충하초의 숙주가 되는 벌레도 7-8종류가 되는 것으로 알려져 있으며 Cordyceps is a phenomenon in which the microorganisms that have been flying in the air attach to insects and take effect from insects in winter and grow like mushrooms in summer, and there are 7-8 kinds of insects that are hosts of cordyceps.
그중에서 쉽게 볼 수 있는 것이 누에 동충하초 입니다.Among them, you can easily see silkworm cordyceps.
포도는 공기 중에 날아니던 미생물이 포도의 껍질표면에 정착을 하고 있으므로 포도는 숙주와 균주룰 동시에 가지고 있습니다.Grapes have both the host and the strain at the same time because microorganisms that have been flying in the air settle on the surface of the grapes.
콩을 메주로 발효시켜 장을 만들고 밀이 누룩이 되여 술을 만드는 이외에도 인삼이 홍삼이 되고 지황이 숙지황이 되어 보혈작용을 하는등 오래 저부터 귀한 약 제를 법제하는데는 미생물을 활용하였습니다.In addition to making soybeans by fermenting soybeans with meju, making wheat into yeast, and making sake, ginseng becomes red ginseng and jihwang sulfur, which is a blood-reducing function.
그런데 이 모두가 미생물의 종류보다는 미생물이 자라는 조건 또는 숙주에 따라서 전혀 다른 효과를 낸다는 것입니다.But all of these have different effects depending on the host or the conditions under which the microorganism grows, rather than the type of microorganism.
이러한 사실을 미루어 볼때 미생물의 종류도 중요하지만 미생물의 환경과 영양을 공급하는 숙주등을 연구하는 것이 더 중요하다고 생각합니다.In light of this fact, the type of microorganism is important, but I think it is more important to study the environment and nutritional host.
일전에 오래 발효된 된장이 항암효과가 증진된다는 연구발포를 보았고 콩의 발효과정을 거치는 동안 메주와 된장은 그 암예방 기능성이 증진되는 사실도 알려져 있습니다.Recently, long-fermented soybean paste had been researched for its anti-cancer effects. Meju and soybean paste are known to improve their cancer prevention function during soybean fermentation.
본 발명은 상기한 콩과 홍삼을 결합시켜 보다 증진된 효과를 낼 수 있게 하는 것으로 콩에서 1차발효된 바실루 서브틸리스균을 홍삼과 혼합하여 2차발효하여 보다 증진된 기능을 가지는 바실루 서브틸리스균을 제조하여 장류를 제조할 수 있도록 한 것인데 이를 보다 상세히 설명하면 다음과 같다.The present invention is to combine the soybean and red ginseng to achieve a more enhanced effect Bacillus subtilis bacteria first fermented in soybeans mixed with red ginseng and the second fermentation Basilu sub having a more enhanced function It is to make tilis by preparing the tilis bacteria, which will be described in more detail as follows.
1) 준비단계1) Preparation
콩, 홍삼분말을 같은량으로 준비한다.Prepare the same amount of beans and red ginseng powder.
2) 제조공정2) manufacturing process
콩을 삶아서 한김을 식힌다음 소쿠리에 담아 서로 어긋나게 포개어 42~45℃의 온도를 유지하는 발효실에 넣고 48시간 발효시키는 1차발효단계와Boil soybeans, cool it, and put it in a colander to overlap each other, put it in a fermentation chamber maintaining a temperature of 42 ~ 45 ℃,
발효실에서 인출하여 10℃로 식힌다음 스크류파쇄기에 투입하여 으깨면서 준비한 홍삼분말을 혼합하는 혼합단계와After the extraction from the fermentation chamber and cooled to 10 ℃ mixed into the screw crusher prepared by mixing the red ginseng powder and
홍삼분말이 혼합된 바실루 서브틸리스균을 소쿠리에 담아 35~38℃를 유지하는 발효실에 넣고 25시간 발효시키는 2차발효단계와 Bacillus subtilis bacteria mixed with red ginseng powder in a colander and put into a fermentation chamber maintained at 35 ~ 38 ℃ and fermentation for 25 hours and
2차 발효된 발효물을 55~60℃의 건조실에서 수분함량이 13중량%가 될때 까지 건조시키는 건조단계와A drying step of drying the second fermented fermented product in a drying room at 55-60 ° C. until the water content is 13% by weight;
건조된 제품을 분쇄기로 분쇄하여 120메쉬 크기로 분말화하는 단계를 순차적으로 실시하여 얻어지는 제조방법이다.It is a manufacturing method obtained by sequentially performing the step of pulverizing the dried product to a size of 120 mesh by milling.
이와 같이 제조된 본 발명은 콩의 발효과정에 관여한 바실루 서브틸리스균이 홍삼분말과 혼합하여 발효에 관여하면서 육성되므로 보다 증진된 기능을 가진 홍삼 바실루 서브틸리스균을 형성하게 되고 이를 된장, 간장, 고추장, 청국장에 10~15중량%를 혼합하여 홍삼된장, 홍삼간장, 홍삼고추장, 홍삼청국장을 제조할 수 있으므로 종래의 청국장보다 증진된 효과를 낼 수 있게 된다.
종래의 청국장도 식중독이나 장염, 세균성설사를 방지하는 효과가 있고 변비, 당뇨, 혈압등에도 좋은 효과가 있으며 DNA 손상억제 효과가 있는 것으로 알려져 있지만 그 정도는 매우 미약하므로 청국장 효능이 5배정도만 향상된 제품이 된다해도 개발가치가 있는데 본 발명은 이를 능가하는 효과가 있다는 것이 입증된 것입니다.In the present invention prepared as described above, Bacillus subtilis bacteria involved in the fermentation process of soybeans are grown while being involved in fermentation by mixing with red ginseng powder to form red ginseng Bacillus subtilis bacteria having a more enhanced function, and miso, Soy sauce, red pepper paste, Cheonggukjang mixed with 10-15% by weight can be produced red ginseng miso, red ginseng soy sauce, red ginseng red pepper paste, red ginseng Cheonggukjang so that it can have an enhanced effect than the conventional Cheonggukjang.
Conventional Cheonggukjang also has the effect of preventing food poisoning, enteritis, bacterial diarrhea, constipation, diabetes, blood pressure, etc. It is known to have the effect of inhibiting DNA damage, but the degree is very weak, so the effect of Cheonggukjang is only 5 times improved. Even if this is a development value, the present invention has proved that it has an effect that exceeds it.
본 발명은 이러한 효과를 확인하기 위해 홍삼 바실루 서브틸리스균을 사용하여 만든 홍삼 청국장을 만들고 그것이 인체에 미치는 효과를 알아보기 위해 성능실험을 하였습니다.
본 실험에서는 Comet assay법을 이용하여, 홍삼 및 청국장 혼합 분말의 희석배율에 따른 항유전독성(DNA 손상억제) 효과를 단일의 홍삼 분말 및 단일의 청국장 분말에 의한 항유전독성 효과와 비교하고, 홍삼 및 청국장 혼합 분말의 혼합비율에 따른 항유전독성 효과를 조사하여 바람직한 혼합비율을 확인한 다음, 홍삼 및 청국장 혼합 분말의 첨가비율을 달리한 식품 조성물들을 제조하여, 상기 식품 조성물들의 항유전독성 효과 실험 및 관능평가를 실시하여 적정한 첨가비율을 확인함으로써 발명의 목적을 달성한 것입니다.
그 결과 홍삼 및 청국장의 혼합 분말로 구성된 본 발명의 식품 첨가제는, 단일의 홍삼 분말 및 단일의 청국장 분말에 비해 훨씬 더 뛰어난 DNA 손상 억제 효능을 나타내는 것을 알 수가 있었으며
항유전독성 효과를 조사하기 위하여, DNA에 스트랜드 브레이크(strand breaks)를 일으키는 발암물질과 같은 유전독성물질을 검색하기 위해 손상된 DNA를 DNA 염색 시약으로 염색한 후 형광 현미경하에서 관찰하여 정확하고 신속하게 분석할 수 있는 싱글셀 전기영동(single cell electrophoresis), 즉 Comet assay법을 이용하였다.
본 발명에서 발암원으로 사용한 직접 발암원인 MNNG(N-Methyl-N'-nitro-N-nitrosoguanidine)는 독일의 Fluka사로부터 구입하여 4℃에서 냉장보관하여 사용하며, 본 발명에서 사용한 세포주는 마우스 엠브로(mouse embryo) 기원의 악성종양이 아닌 정상적인(non-tumoral nomal) 3T3 세포(ATCC CCL No. 163)로서, 한국 세포주은행으로부터 분양받아 사용한다.
세포주의 배양 및 보존을 위해서는 박 등의 방법에 따라 DMEM(Dulbecco's modified Eagle's mediument, Sigma U.S.A)에 우혈청(calf serum;Gibco, U.S.A)을 10, 페니실린 G(sigma, U.S.A) 100unit/mL, 스트렙토마이신 술페이트(streptomycin sulfate)(sigma, U.S.A) 100㎕/mL을 첨가하여 사용하며, 직경 10cm의 둥근 조직배양접시(Falcon, U.S.A)에서 37℃, 5% CO2를 유지하는 습윤배양기(Labline instrument, U.S.A)로 배양을 실시하고, 또 주 2회 정도로 세포가 융합(confluent)에 이르기 전에 계대를 실시하여 20계대를 넘기면 폐기하고 새로운 세포로 대체하여 실험에 이용했다.
(실험 결과)
단일 홍삼 분말의 항유전독성 효과
단일 홍삼 분말의 항유전독성 효과를 측정하기 위하여, 먼저 홍삼 분말(풍기인삼공사)을 증류수에 24시간 녹인 후 원심분리하여 상등액을 얻었다. 이 상등액을 3번 필터링하여 얻어 낸 용액을 딥 프리저(deep freezer)에 24시간 동안 얼린 후 동결건조 시켜 홍삼 농축 분말 가루를 얻었다. 이 분말 200g을 증류수 1ℓ에 녹여 원액을 제조한 후, 이 원액 100㎕와 증류수 900㎕를 섞어줌으로서 원액을 10배로 희석하였다. 같은 방법으로 100배, 1000배 희석하여 각각의 희석액을 얻었다.
본 실험에 이용한 세포주는 3T3 세포를 이용하였으며, 상기 3T3 세포를 1×105개로 초기 접종한 후 48시간 동안 37℃, 5% CO2 습윤 배양기에서 배양하여 DNA 손상 억제 효과를 조사하였다. 이 때, 양성 대조구로는 MNNG만을 처리한 세포를 사용하였다.
먼저 상기 3T3 세포에 발암물질인 MNNG 1mg을 5ml의 PBS 용액에 녹여 각각 처리구에 10㎕씩 처리하여 3T3 세포의 DNA를 손상시킨 후, 여기에 상기 홍삼 추출물 원액, 10배 희석액, 100배 희석액 및 1000배 희석액 각각을 10㎕씩 HBSS와 혼합 처리하여 DNA 손상 복구 정도를 Comet assay를 통하여 확인하였다. DNA 손상 억제 효과를 관찰하기 전에 먼저 상기 3T3 세포를 알칼리 버퍼 125ml, DMSO 25ml 및 트리톤-x 2.5ml의 혼합용액에 담가 1시간 냉장 보관한 상태에서 그 막을 용해시켰으며, 이를 NaCl과 EDTA가 들어있는 전기영동 버퍼에서 20분간 전 반응시킨 후, 300mA, 25V에서 20분간 전기영동을 실시하였다. 그 후 상기 세포를 중화 버퍼(neutralization buffer)에 5분간 담가 중화시킨 뒤, 슬라이드의 손잡이 부분을 건조시키고, DNA 손상 정도를 살펴보기 위하여 형광 염색시약 YOYO-1을 PBS와 1:1로 희석한 염색약(Molecular probes, USA) 75㎕로 염색하였다. 염색된 슬라이드는 형광현미경(CSB-FEI, China) 상에서 배율 250배로 관찰하였다.
그 결과, 도 1에 나타낸 바와 같이, 양성 대조구에서의 DNA 손상 정도는 250이었으나, 홍삼 추출물 원액에서의 DNA 손상 정도는 187로 나타나, 홍삼 추출물 원액이 뛰어난 항유전독성 효과를 가짐을 보여주었다. 한편, 홍삼 추출물의 100배 희석액 및 1000배 희석액에서는 DNA 손상 정도가 각각 242, 248의 양성 대조구와 비슷한 결과로 나타나 거의 항유전독성 효과가 없는 것으로 판단되었다.
(도 1)단일 홍삼 분말의 항유전독성 효과
단일 청국장 분말의 항유전독성 효과
단일 청국장 분말의 항유전독성 효과를 측정하기 위해, 청국장 분말(가야원)을 사용하여 위와 동일한 방법으로 Comet assay를 실시하였다.
그 결과, 도 2에서 알 수 있는 바와 같이, 단일 청국장 분말의 항유전독성 효과는 단일 홍삼 분말의 경우와 비슷하게 나타났다. 즉, 청국장 추출물 원액의 DNA 손상 정도는 175로 홍삼보다 조금 더 탁월한 항유전독성 효과를 나타내었으며, 100배 희석액은 DNA 손상 정도가 247, 1000배 희석액은 DNA 손상 정도가 249로 거의 DNA 손상 억제 효과가 없는 것으로 나타났다.
(도 2)단일 청국장 분말의 항유전 독성 효과
홍삼 및 청국장 혼합 분말의 항유전독성 효과
홍삼 분말과 청국장 분말을 30:70(w/w)의 비로 혼합하여 혼합 분말 200 g을 얻은 뒤, 그 혼합 분말의 항유전독성 효과를 위에서와 동일한 방법으로 측정하였다.
그 결과, 도 3에 나타낸 바와 같이, 홍삼 분말과 청국장 분말을 혼합한 경우에는 상기 홍삼 분말과 청국장 분말을 각각 따로 분리하여 항유전독성 효과를 조사한 경우보다 그 효과가 훨씬 크다는 사실을 확인할 수 있었다.
즉, 홍삼 추출물 원액에서는 DNA 손상 정도가 187로 나타나고, 청국장 추출물 원액에서는 175로 나타난데 반해, 홍삼 및 청국장 혼합 추출물 원액에서는 155 내외로 현저히 적게 나타났으며, 상기 단일의 홍삼 추출물 및 청국장 추출물과 달리 홍삼 및 청국장의 혼합 추출물에서는 그 1000배 희석액에서도 DNA 손상 정도가 양성 대조구(250)보다 적은 214로 나타나, 충분한 정도의 DNA 손상 억제 효과가 있음을 알 수 있었다.
결론적으로, 본 발명의 홍삼 및 청국장의 혼합 분말은 1000배까지 희석된 상태로 식품에 첨가되어도 충분히 항유전독성을 나타낼 수 있을 것으로 기대되었다.
(도 3)홍삼 및 청국장 혼합 분말의 항유전독성 효과
홍삼 및 청국장 혼합 분말의 DNA 손상 복구 정도
홍삼, 청국장 그리고 홍삼 청국장 혼합 추출물을 분리하여 이들의 항유전독성 효과를 서로 조사 비교하였다.
도 4에서 볼 수 있는 대로 홍삼 청국장 혼합 추출물의 항유전독성 효과는 크게 나타났으며 단독으로 사용하는 것 보다 혼합 추출물은 synergistic한 효과가 나타나는 것으로 보여진다.
DNA 손상 억제는 도 5에서 보여지는 바와 같이 홍삼 청국장 추출물 원액에서는 37%의 억제 효과가 있는 것으로 나타났으며 10배 희석 액에서는 20% 억제 효과가 있으며 100배 희석 액에는 16% 그리고 1000배 희석 액에는 14%로 항유전독성 효과가 있는 것으로 나타났다.
(도 4)홍삼 청국장의 항유전독성 효과 비교
(도 5)DNA 손상 복구 정도
The present invention was made to test the effect of the red ginseng Cheonggukjang made by using the red ginseng bacillus subtilis bacteria to confirm this effect and to see the effect on the human body.
In this experiment, the antigenetic toxicity (DNA damage inhibition) effect according to the dilution ratio of red ginseng and Cheonggukjang mixed powder was compared with the antigenetic toxicity effect of single red ginseng powder and single Cheonggukjang powder using Comet assay. And by checking the anti-genetic toxicity effect according to the mixing ratio of the Cheonggukjang mixed powder, to determine the preferred mixing ratio, and to prepare food compositions with different addition ratios of the red ginseng and Cheonggukjang mixed powder, to test the anti-genetic toxicity effect of the food compositions and The objective of the invention was achieved by performing a sensory evaluation to confirm the proper addition ratio.
As a result, the food additive of the present invention composed of a mixture of red ginseng and Cheonggukjang showed much better DNA damage inhibition effect than a single red ginseng powder and a single Cheonggukjang powder.
In order to investigate the antigenetic effects, to detect genotoxic substances such as carcinogens that cause strand breaks in DNA, damaged DNA is stained with DNA staining reagent and observed under fluorescence microscope for accurate and rapid analysis. Single cell electrophoresis, that is, Comet assay was used.
MNNG (N-Methyl-N'-nitro-N-nitrosoguanidine), which is a direct carcinogen used in the present invention, is purchased from Fluka, Germany, and refrigerated at 4 ° C. The cell line used in the present invention is mouse M. Non-tumoral nomal 3T3 cells (ATCC CCL No. 163), which are not malignant tumors of broth (mouse embryo) origin, are available from Korea Cell Line Bank.
For culture and preservation of cell lines, DMEM (Dulbecco's modified Eagle's mediument, Sigma USA) was charged with calf serum (Gibco, USA) 10, penicillin G (sigma, USA) 100 units / mL, streptomycin 100 μl / mL of streptomycin sulfate (sigma, USA) is added, and a wet culture apparatus (Labline instrument, USA) maintains 37 ° C. and 5% CO 2 in a 10 cm diameter round tissue culture dish (Falcon, USA). Culture was carried out), and the cells were passaged twice a week before reaching confluent, discarded after 20 passages, and replaced with new cells.
(Experiment result)
Antigenotoxic Effects of Single Red Ginseng Powder
In order to measure the anti-genetic toxicity of the single red ginseng powder, first, the red ginseng powder (Punggi ginseng Corp.) was dissolved in distilled water for 24 hours and centrifuged to obtain a supernatant. The supernatant was filtered three times, and the resulting solution was frozen in a deep freezer for 24 hours and then lyophilized to obtain red ginseng concentrate powder. 200 g of this powder was dissolved in 1 L of distilled water to prepare a stock solution. The stock solution was diluted 10 times by mixing 100 µl of the stock solution and 900 µl of distilled water. In the same manner, dilutions were obtained 100 and 1000 times to obtain respective dilutions.
The cell line used in this experiment was used 3T3 cells, and the initial inoculation of the 3T3 cells to 1 × 105 cells were incubated for 48 hours at 37 ℃, 5% CO2 wet incubator to investigate the DNA damage inhibition effect. At this time, a cell treated with only MNNG was used as a positive control.
First, 1 mg of MNNG, a carcinogen to 3T3 cells, was dissolved in 5 ml of PBS solution, and then treated with 10 μl of each treatment to damage DNA of 3T3 cells, followed by the red ginseng extract solution, 10-fold dilution, 100-fold dilution, and 1000. 10 µl each of the pear dilutions was mixed with HBSS to determine the extent of DNA damage recovery through the Comet assay. Before observing the effect of inhibiting DNA damage, the 3T3 cells were first immersed in a mixed solution of 125 ml of alkaline buffer, 25 ml of DMSO and 2.5 ml of Triton-x, and refrigerated for 1 hour. The membranes were dissolved in NaCl and EDTA. After 20 minutes pre-reaction in the electrophoresis buffer, electrophoresis was performed for 20 minutes at 300mA, 25V. Subsequently, the cells were immersed in a neutralization buffer for 5 minutes and neutralized. Then, the handles of the slides were dried, and the dye was diluted 1: 1 with PBS in a fluorescent dye reagent YOYO-1 to examine the degree of DNA damage. (Molecular probes, USA) stained with 75ul. Stained slides were observed at 250 × magnification on a fluorescence microscope (CSB-FEI, China).
As a result, as shown in Figure 1, the DNA damage in the positive control was 250, but the DNA damage in the red ginseng extract undiluted solution was 187, showing that the red ginseng extract has an excellent antigenetic effect. On the other hand, in the 100-fold and 1000-fold dilutions of red ginseng extract, the degree of DNA damage was similar to that of the positive control of 242 and 248, respectively.
(FIG. 1) Antigenotoxic Effects of Single Red Ginseng Powder
Antigenotoxic Effects of Single Cheonggukjang Powder
In order to measure the anti-genetic toxicity of a single Cheonggukjang powder, a Comet assay was performed using the Cheonggukjang powder (Kayawon) in the same manner as above.
As a result, as can be seen in Figure 2, the anti-genetic effect of the single Cheonggukjang powder appeared similar to the case of a single red ginseng powder. In other words, the DNA damage of the Cheonggukjang extract was 175, which was more excellent than the red ginseng. The 100-fold dilution was 247, and the 1000-fold dilution was 249. Appeared to be absent.
(FIG. 2) Antigenetic Toxicity Effect of Single Cheonggukjang Powder
Antigenotoxic Effects of Red Ginseng and Cheonggukjang Mixtures
Red ginseng powder and Cheonggukjang powder were mixed in a ratio of 30:70 (w / w) to obtain 200 g of mixed powder, and then the antigenetic effect of the mixed powder was measured in the same manner as above.
As a result, as shown in Figure 3, when the red ginseng powder and Cheonggukjang powder was mixed, it was confirmed that the effect is much greater than the case of separately separating the red ginseng powder and Cheonggukjang powder to investigate the anti-genetic effects.
In other words, the amount of DNA damage was 187 in the red ginseng extract and 175 in the chungkukjang extract, whereas the red ginseng and the Cheonggukjang extracts were markedly less than 155 in the mixed extract of the red ginseng extract. In the mixed extract of red ginseng and Cheonggukjang, the DNA damage was 214 less than that of the positive control 250 even in the 1000-fold dilution, indicating that the DNA damage was sufficiently inhibited.
In conclusion, the mixed powder of red ginseng and Cheonggukjang of the present invention was expected to exhibit sufficient anti-genetic toxicity even when added to foods diluted up to 1000 times.
(FIG. 3) Antigenotoxic effect of red ginseng and Cheonggukjang mixed powder
DNA Damage Recovery Level of Red Ginseng and Cheonggukjang Mix Powder
Red ginseng, Cheonggukjang and red ginseng Cheonggukjang mixed extracts were isolated and their anti-genetic effects were investigated.
As shown in Figure 4, the anti-genetic toxicity effect of the red ginseng Cheonggukjang mixed extract was shown to be large, and the mixed extract was shown to have a synergistic effect than used alone.
As shown in FIG. 5, inhibition of DNA damage was shown to have 37% inhibitory effect in the red ginseng chungkukjang extract undiluted solution, 20% inhibitory effect in 10-fold dilutions, and 16% and 1000-fold dilutions in 100-fold dilutions. Had antigenotoxic effect of 14%.
(Figure 4) Comparison of anti-genetic toxicity effect of red ginseng Cheonggukjang
(Figure 5) DNA damage recovery degree
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030083106 | 2003-11-21 | ||
KR20030083106 | 2003-11-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050049309A KR20050049309A (en) | 2005-05-25 |
KR100714408B1 true KR100714408B1 (en) | 2007-05-07 |
Family
ID=37247845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040040252A KR100714408B1 (en) | 2003-11-21 | 2004-06-03 | Method for manufacturing of red ginseng bacillus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100714408B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101144471B1 (en) | 2009-11-04 | 2012-05-11 | 김태윤 | Method for preparing new protein having function and anticancer effects |
KR101324282B1 (en) | 2012-06-25 | 2013-11-01 | 서범구 | Preparation method of fermented red ginseng for improving immunity of the human body using effective micro-organisms |
KR20180003186A (en) * | 2016-06-30 | 2018-01-09 | (주)미토스바이오 | Fermented gluten-safe wheat flour |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100603071B1 (en) * | 2004-09-17 | 2006-07-24 | 신현길 | A food additive having antigenotoxic effect which contains mixed powders of red ginseng and Chungkook-jang and a food composition comprising the same |
KR100738579B1 (en) * | 2005-06-09 | 2007-07-11 | 주식회사 하이닉스반도체 | Semiconductor memory deivce |
KR100849660B1 (en) * | 2006-11-17 | 2008-08-01 | 주식회사 에이치브이엘에스 | Ginseng preparations containing a high concentration of ginseng sapogenin using a Bacillus natto and method thereof |
KR100866610B1 (en) * | 2007-05-07 | 2008-11-03 | 경북대학교 산학협력단 | A preparation method of red ginseng cheonggukjang and hydrolysate thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030041923A (en) * | 2003-04-30 | 2003-05-27 | 김재백 | Red ginseng containing deglycosylated ginsenosides and its manufacturing method. |
KR20030061756A (en) * | 2003-06-25 | 2003-07-22 | 오인교 | Preparation Method of Ginseng Extracts with High Functionality and Flavor |
-
2004
- 2004-06-03 KR KR1020040040252A patent/KR100714408B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030041923A (en) * | 2003-04-30 | 2003-05-27 | 김재백 | Red ginseng containing deglycosylated ginsenosides and its manufacturing method. |
KR20030061756A (en) * | 2003-06-25 | 2003-07-22 | 오인교 | Preparation Method of Ginseng Extracts with High Functionality and Flavor |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101144471B1 (en) | 2009-11-04 | 2012-05-11 | 김태윤 | Method for preparing new protein having function and anticancer effects |
KR101324282B1 (en) | 2012-06-25 | 2013-11-01 | 서범구 | Preparation method of fermented red ginseng for improving immunity of the human body using effective micro-organisms |
KR20180003186A (en) * | 2016-06-30 | 2018-01-09 | (주)미토스바이오 | Fermented gluten-safe wheat flour |
KR102063897B1 (en) * | 2016-06-30 | 2020-01-08 | (주)미토스바이오 | Fermented gluten-safe wheat flour |
Also Published As
Publication number | Publication date |
---|---|
KR20050049309A (en) | 2005-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Saharan et al. | Comparative assessment of effect of fermentation on phenolics, flavanoids and free radical scavenging activity of commonly used cereals | |
Juan et al. | Fermentation with Bacillus spp. as a bioprocess to enhance anthocyanin content, the angiotensin converting enzyme inhibitory effect, and the reducing activity of black soybeans | |
Sadh et al. | Bio-augmentation of antioxidants and phenolic content of Lablab purpureus by solid state fermentation with GRAS filamentous fungi | |
KR101968242B1 (en) | Lactobacillus brevis ami-1109 and use thereof | |
KR100714408B1 (en) | Method for manufacturing of red ginseng bacillus | |
KR100919070B1 (en) | Process for the preparation of fermentation product of esculent roots using microorganism having fermentation activity of saponin-containing esculent roots | |
KR20130031034A (en) | Reduction of biogenic amines in the fermented food by the plants extracts | |
CN114592013A (en) | Preparation method and application of cordyceps sobolifera enzyme | |
JP2021530215A (en) | Microbiological process for bee pollen production | |
KR20170010927A (en) | Brown rice containing GABA coated with rice flour fermentation products and the manufacturing method thereof | |
KR101796494B1 (en) | Lactobacillus pentosus-GFC LP | |
KR20170073058A (en) | the fermented samultang extracting method with the function of both anti-oxidation and immunity and the samultang extract using thereof | |
KR100945670B1 (en) | Composition of healthy food containing fermented soybean powder | |
KR20200101382A (en) | Vertical plug-flow process for bio-conversion | |
KR101176158B1 (en) | soy bean milk and fermented soy bean milk and manufacturing method there of, sauce and dressing with powder of soy bean milk that was fermented by deep sea water and manufacturing method there of | |
KR100431277B1 (en) | functional Chungkookjang and process for preparation thereof | |
KR20190080383A (en) | Fermented Korean mistletoe extract complising lections and preparation method of the same | |
KR20170120053A (en) | the fermented samultang extracting method with the function of both anti-oxidation and immunity and the samultang extract using thereof | |
KR20190050319A (en) | Feed for Black Goat Using Fermented Platycodon and Its Production Method | |
KR102125363B1 (en) | Manufacturing method of powder yeast for making grain wine | |
Cante et al. | Optimization of Mixing Conditions for Improving Lactobacillus Paracasei Cba L74’S Growth During Lactic Fermentation of Cooked Navy Beans and Functional Characterization of the Fermented Products | |
CN108611279B (en) | Domestication method of sorangium cellulosum, domesticated sorangium cellulosum and application | |
KR101817776B1 (en) | Lespedeza cuneata G.Don Fermented extract Using Lactobacillus pentosus-GFC LP and Method for Preparing the Same | |
TW202400125A (en) | Uses of trans-3-indoleacrylic acid and 4-glucosylvanillic acid in preparing composition for reducing fat and a fat reducing composition | |
Stiti et al. | Agri-food valuation of oak fruits in human consumption: Formulation of desserts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120316 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20130306 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140925 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150526 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160226 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180418 Year of fee payment: 12 |